中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

四君子汤合五苓散加减辨治脾虚水停证肝硬化腹水患者的临床效果

杨红莉1 ,刘平2

(1.韩城市人民医院,陕西 渭南,715400;2.西安济仁医院,陕西 西安,710300)

浏览次数:684次 下载次数:341次

摘要:

目的 探讨四君子汤合五苓散加减对脾虚水停证肝硬化腹水的治疗效果。方法 抽取我院2014 年1 月至2016 年12 月 接收的90 例脾虚水停证肝硬化腹水患者作为研究对象,按数字奇偶法分为对照组和研究组,每组45 例。对照组患者给予利 尿、加强营养、保肝及维持酸碱、水电解质平衡的常规西医治疗,研究组患者在对照组基础上再给予四君子汤合五苓散加减 进行治疗,观察两组患者临床疗效及治疗后肝功能和腹水量积分情况。结果 研究组治疗总有效率为95.56%,显著高于对照 组的77.78%(P<0.05);治疗后,两组患者腹水量积分明显降低,且研究组显著低于对照组(P<0.05);研究组患者肝功能各指 标水平优于对照组,差异具有统计学意义(P<0.05)。结论 对脾虚水停证肝硬化腹水患者应用四君子汤合五苓散加减治疗,临床疗效显著,患者肝功能指标明显改善,腹水量积分显著降低。

关键词:肝硬化腹水;脾虚水停证;四君子汤联合五苓散加减

中图分类号:R259文献标志码:A文章编号:2096-1413(2017)36-0122-02

    Clinical effect observation of Sijunzi decoction combined with modified Wuling powder in the dialectical treatment of patients with liver cirrhosis and ascites of spleen deficiency water cessation
    YANG Hong-li 1, LIU Ping 2
    (1. the People``s Hospital of Hancheng, Weinan 715400; 2. Xi``an Jiren Hospital, Xi``an 710300, China)

    ABSTRACT: Objective To explore the effect of Sijunzi decoction combined with modified Wuling powder in the
    dialectical treatment of patients with liver cirrhosis and ascites of spleen deficiency water cessation. Methods A total of 90 patients with cirrhosis and ascites of spleen deficiency water cessation who treated in our hospital from January 2014 to December 2016 were enrolled in this study. They were divided into control group and study group according to the number parity method, with 45 cases in each group. The control group was treated with diuresis, enhanced nutrition, maitaining balance of acid and alkali, water and electrolyte and other conventional western medicine treatment, while the study group was given Sijunzi decoction combined with modified Wuling powder on the basis of the control group. The clinical efficacy, liver function and ascites amount scores after treatment were observed in the two groups. Results The total effective rate of the study group was 95.56%, which was significantly higher than 77.78% of the control group (P<0.05). After treatment, the scores of ascites in the two groups significantly decreased, and that in the study group was significantly lower than the control group (P<0.05). The levels of liver function indexes in the study group were better than those in the control group, the differences were statistically significant (P<0.05). Conclusion For patients with liver cirrhosis and ascites of spleen deficiency water cessation, Sijunzi decoction and modified Wuling powder has significant clinical effect, it can effectively improve liver function and reduce scores of ascites.
    KEYWORDS: liver cirrhosis and ascites; spleen deficiency water cessation; Sijunzi decoction and modified Wuling powder

    参考文献:
    [1] 张毅,孔德润.肝硬化腹水并自发性细菌性腹膜炎的危险因素分析 [J].安徽医科大学学报,2016,51(11):1647-1650.
    [2] 中华中医药学会脾胃病分会.肝硬化腹水中医诊疗规范专家共 识意见(2011 年,海南)[J].中国中西医结合杂志,2012,32(12):1692-1696.
    [3] 周仲瑛.中医内科学[M].2 版.北京:中国中医药出版社,2007:71-76.
    [4] 余松,朱肖鸿,付淑艳,等.四君子汤合调营汤加减治疗脾虚湿盛兼 血瘀型肝硬化腹水的疗效观察[J].中西医结合肝病杂志,2012,22(4):240-241.
    [5] 国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科 技出版社,2012:11.
    [6] 高玉华.加减五苓散联合恩替卡韦对乙型肝炎肝硬化腹水患者的 临床疗效研究[J].环球中医药,2012,5(10):775-777.
    [7] 黄志强,丁庆学.肾气丸和五苓散联合西药治疗肝硬化腹水38 例 [J].光明中医,2015,30(7):1502-1503.
    [8] 刘书芳.小柴胡汤合五苓散治疗肝硬化腹水临床观察[J].北方药 学,2016,13(11):112-113.
    [9] 赵金豹.五苓散加减联合西药治疗乙肝后肝硬化腹水56 例[J].河 南中医,2013,33(6):895-896.
    [10] 刘承岭.一贯煎合五苓散联合西药治疗乙肝肝硬化腹水50 例临 床研究[J].中国现代医生,2014,52(30):28-30.

上一篇荜拔、黄连、栀子为主药的穴位敷贴治疗慢性胃炎的临床效果

下一篇宽胸气雾剂治疗寒凝气滞型不稳定性心绞痛临床疗效观察